Search research articles
Contact Us
Filters
Showing results (21-30 of 67) with videos related to
Page
of 7
Sort By:
Science Advances
|
February 25, 2022
Therapeutic antibody activation of the glucocorticoid-induced TNF receptor by a clustering mechanism
Changhao He, Rachana R Maniyar, Yahel Avraham, et al.
Cancer Immunology Research
|
May 6, 2014
Combination of alphavirus replicon particle-based vaccination with immunomodulatory antibodies: therapeutic activity in the B16 melanoma mouse model and immune correlates
Francesca Avogadri, Roberta Zappasodi, Arvin Yang, et al.
Journal for Immunotherapy of Cancer
|
March 14, 2023
Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors
Harriet Kluger, J Carl Barrett, Justin F Gainor, et al.
Archives of Biochemistry and Biophysics
|
July 18, 2020
Silibinin down-regulates PD-L1 expression in nasopharyngeal carcinoma by interfering with tumor cell glycolytic metabolism
Leïla Sarah Sellam, Roberta Zappasodi, Fayçal Chettibi, et al.
Cancer Research
|
September 24, 2010
Tumor-reactive CD8+ early effector T cells identified at tumor site in primary and metastatic melanoma
Andrea Anichini, Alessandra Molla, Claudia Vegetti, et al.
Cancer Research
|
October 2, 2010
Improved clinical outcome in indolent B-cell lymphoma patients vaccinated with autologous tumor cells experiencing immunogenic death
Roberta Zappasodi, Serenella M Pupa, Gaia C Ghedini, et al.
Hematological Oncology
|
July 22, 2017
Microenvironment modulation and enhancement of antilymphoma therapy by the heparanase inhibitor roneparstat
Anna Rossini, Franco Zunino, Giusi Ruggiero, et al.
Advances in Cancer Research
|
July 29, 2015
The New Era of Cancer Immunotherapy: Manipulating T-Cell Activity to Overcome Malignancy
Danny N Khalil, Sadna Budhu, Billel Gasmi, et al.
The Journal of Clinical Investigation
|
September 3, 2024
Pharmacologic LDH inhibition redirects intratumoral glucose uptake and improves antitumor immunity in solid tumor models
Svena Verma, Sadna Budhu, Inna Serganova, et al.
Blood
|
September 24, 2008
Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study
Massimo Di Nicola, Roberta Zappasodi, Carmelo Carlo-Stella, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 67) with videos related to
Sort By:
Page
of 7
Science Advances
|
February 25, 2022
Therapeutic antibody activation of the glucocorticoid-induced TNF receptor by a clustering mechanism
Changhao He, Rachana R Maniyar, Yahel Avraham, et al.
Cancer Immunology Research
|
May 6, 2014
Combination of alphavirus replicon particle-based vaccination with immunomodulatory antibodies: therapeutic activity in the B16 melanoma mouse model and immune correlates
Francesca Avogadri, Roberta Zappasodi, Arvin Yang, et al.
Journal for Immunotherapy of Cancer
|
March 14, 2023
Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors
Harriet Kluger, J Carl Barrett, Justin F Gainor, et al.
Archives of Biochemistry and Biophysics
|
July 18, 2020
Silibinin down-regulates PD-L1 expression in nasopharyngeal carcinoma by interfering with tumor cell glycolytic metabolism
Leïla Sarah Sellam, Roberta Zappasodi, Fayçal Chettibi, et al.
Cancer Research
|
September 24, 2010
Tumor-reactive CD8+ early effector T cells identified at tumor site in primary and metastatic melanoma
Andrea Anichini, Alessandra Molla, Claudia Vegetti, et al.
Cancer Research
|
October 2, 2010
Improved clinical outcome in indolent B-cell lymphoma patients vaccinated with autologous tumor cells experiencing immunogenic death
Roberta Zappasodi, Serenella M Pupa, Gaia C Ghedini, et al.
Hematological Oncology
|
July 22, 2017
Microenvironment modulation and enhancement of antilymphoma therapy by the heparanase inhibitor roneparstat
Anna Rossini, Franco Zunino, Giusi Ruggiero, et al.
Advances in Cancer Research
|
July 29, 2015
The New Era of Cancer Immunotherapy: Manipulating T-Cell Activity to Overcome Malignancy
Danny N Khalil, Sadna Budhu, Billel Gasmi, et al.
The Journal of Clinical Investigation
|
September 3, 2024
Pharmacologic LDH inhibition redirects intratumoral glucose uptake and improves antitumor immunity in solid tumor models
Svena Verma, Sadna Budhu, Inna Serganova, et al.
Blood
|
September 24, 2008
Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study
Massimo Di Nicola, Roberta Zappasodi, Carmelo Carlo-Stella, et al.
Page
of 7